article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

While the complexity of distribution networks makes counterfeit detection difficult, the research highlighted a framework for using smart contracts and distributed ledgers to tackle this problem in the drug supply chain. In conclusion, Kordestani et al. In conclusion, Kordestani et al.

article thumbnail

Network Optimization Strategies for Payers: A Look at Provider Network Adequacy

Clarify Health

A well-balanced and adequately resourced provider network is a strategic asset for payers in the highly competitive healthcare insurance market. When looking to optimize, it is critical to ensure network adequacy or the provider network’s ability to meet the healthcare needs of an insured population.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Distribute Content to Doctors (Plus, 7 Tips on Email Marketing to Doctors)

Healthcare Success

Here they are again for your ease of reference: Step 1: Lead Generation that Works Step 2: Define Your Doctor Audience Step 3: Create Content They Want and Need Step 4: Promote and Distribute Your Content Effectively Step 5: Implement Marketing Strategies to Build Doctor Referrals or Direct Sales Step 6: Track, Measure, and Optimize.

Doctors 101
article thumbnail

Peli BioThermal Unveils Southern California Network Station

Pharmaceutical Commerce

New space will assist pharma companies with cold chain solutions, including commercial product distribution.

article thumbnail

Cybersecurity in the Connected Medical Future

MedCity News

The healthcare industry of the future will be defined by interoperable systems that need to securely share critical data across devices, distributed applications, and networks. Device manufacturers play a pivotal role in the delivery of these secure and connected solutions

Medical 121
article thumbnail

Clover collaborates with Kyuan Trade to launch AdimFlu-S (QIS) in China

Pharmaceutical Technology

Clover Biopharmaceuticals will use Kyuan Trade’s extensive sales and distribution network to complement its in-house capabilities and increase access to its AdimFlu-S (QIS) across the country. The Chinese market for the seasonal influenza vaccine has been growing by 30% per year.

article thumbnail

Episode 63 – In the C-Suite with Daniel Cloutier, CEO, LOK Corporation

Medical Device Success

Understanding how the worldwide distribution ecosystem works is a must for any MedTech professional. This conversation with Daniel Cloutier provides a window into this world and how LOK brings value to the manufacturers it represents with turnkey distribution. Reading time: 2 – 2 minutes. Take a guess at what country that is.